LogicBio Therapeutics, Inc. Long-term Debt, Gross
LogicBio Therapeutics, Inc. had Long-term Debt, Gross of $5.93 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2022-11-14
- 2022-09-30: Long-term Debt, Gross $5.93M.
- 2022-06-30: Long-term Debt, Gross $6.73M.
- 2022-03-31: Long-term Debt, Gross $7.51M.
- 2021-12-31: Long-term Debt, Gross $8.30M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2022-09-30 | $5.93M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.73M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $7.51M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $8.30M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $9.08M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $9.86M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.07M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $10.02M 10-K · filed 2022-03-04 |
| 2020-09-30 | $9.97M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $9.91M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $9.86M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $9.81M 10-K · filed 2021-03-15 |
| 2019-09-30 | $9.76M 10-Q · filed 2019-11-12 |